Maryland State Retirement & Pension System Acquires Shares of 19,215 Enovis Corporation (NYSE:ENOV)

Maryland State Retirement & Pension System bought a new position in shares of Enovis Corporation (NYSE:ENOV - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 19,215 shares of the company's stock, valued at approximately $734,000.

A number of other institutional investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. grew its stake in shares of Enovis by 10.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 712,810 shares of the company's stock worth $27,236,000 after acquiring an additional 67,021 shares during the period. Vanguard Group Inc. boosted its stake in Enovis by 11.3% in the 1st quarter. Vanguard Group Inc. now owns 6,107,199 shares of the company's stock worth $233,356,000 after purchasing an additional 621,069 shares during the period. Leisure Capital Management boosted its stake in Enovis by 2.2% in the 1st quarter. Leisure Capital Management now owns 22,903 shares of the company's stock worth $875,000 after purchasing an additional 489 shares during the period. US Bancorp DE raised its holdings in shares of Enovis by 2.5% in the 1st quarter. US Bancorp DE now owns 19,031 shares of the company's stock valued at $727,000 after acquiring an additional 462 shares in the last quarter. Finally, Natixis Advisors LLC raised its holdings in shares of Enovis by 4.0% in the 1st quarter. Natixis Advisors LLC now owns 20,157 shares of the company's stock valued at $770,000 after acquiring an additional 776 shares in the last quarter. 98.45% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have commented on ENOV shares. UBS Group decreased their price target on Enovis from $65.00 to $57.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. JMP Securities dropped their price target on Enovis from $62.00 to $55.00 and set a "market outperform" rating on the stock in a research report on Friday, May 9th. Wells Fargo & Company dropped their target price on Enovis from $48.00 to $41.00 and set an "overweight" rating on the stock in a report on Friday, August 8th. Evercore ISI decreased their price target on Enovis from $48.00 to $46.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Finally, Needham & Company LLC decreased their price target on Enovis from $57.00 to $49.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, Enovis currently has a consensus rating of "Buy" and a consensus target price of $51.00.

Enovis Trading Up 2.6%

ENOV stock traded up $0.74 during midday trading on Friday, reaching $29.56. 1,055,470 shares of the company traded hands, compared to its average volume of 1,513,643. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.15 and a current ratio of 2.25. The business has a 50 day moving average of $30.33 and a 200-day moving average of $34.58. Enovis Corporation has a 52-week low of $25.47 and a 52-week high of $49.83. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of -2.07 and a beta of 1.70.

Enovis (NYSE:ENOV - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.05. The company had revenue of $564.50 million for the quarter, compared to analysts' expectations of $555.80 million. Enovis had a positive return on equity of 6.78% and a negative net margin of 37.80%. Enovis's revenue was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.62 earnings per share. As a group, sell-side analysts expect that Enovis Corporation will post 2.79 earnings per share for the current fiscal year.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.